Deerfield Management Company, L.P. (Series C) Legend Biotech Corp Transaction History
Deerfield Management Company, L.P. (Series C)
- $3.95 Billion
- Q1 2025
A detailed history of Deerfield Management Company, L.P. (Series C) transactions in Legend Biotech Corp stock. As of the latest transaction made, Deerfield Management Company, L.P. (Series C) holds 1,743,555 shares of LEGN stock, worth $72.4 Million. This represents 1.5% of its overall portfolio holdings.
Number of Shares
1,743,555
Previous 1,551,718
12.36%
Holding current value
$72.4 Million
Previous $50.5 Million
17.16%
% of portfolio
1.5%
Previous 1.25%
Shares
2 transactions
Others Institutions Holding LEGN
# of Institutions
230Shares Held
73.6MCall Options Held
247KPut Options Held
406K-
Westfield Capital Management CO LP Boston, MA6.92MShares$287 Million1.21% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.73MShares$279 Million0.03% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$248 Million6.23% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$237 Million0.01% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.75MShares$156 Million5.57% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $6.95B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...